Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
drugs
fda
life sciences
national blog main
2
×
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
barry greene
biotech
blueprint medicines
boston
boston university
boulder/denver blog main
boulder/denver top stories
cancer
companion diagnostic
dan ollendorf
detroit blog main
detroit top stories
dna sequencing
entrectinib
express scripts
foundation medicine
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
john berk
josh bilenker
keytruda
larotrectinib
What
fda
medicine
2
×
time
2
×
ago
alnylam
approve
approved
awaits
biological
cancer
crossed
decades
decision
deeper
discovered
dna
drug
fingerprint
fingers
friday
genetic
going
historic
matter
nd
new
oks
patients
rna
second
targets
tissues
trick
tumor's
uses
world
Language
Current search:
medicine
×
time
×
" national blog main "
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
